Kevin Marsh/N Engl J Med

Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children.Olotu A Fegan G Wambua J Nyangweso G Leach A Lievens M Kaslow DC Njuguna P Marsh K Bejon P
N Engl J Med, (2016). 374:2519-29

Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine.Neafsey DE Juraska M Bedford T Benkeser D Valim C Griggs A Lievens M Abdulla S Adjei S Agbenyega T Agnandji ST Aide P Anderson S Ansong D Aponte JJ Asante KP Bejon P Birkett AJ Bruls M Connolly KM D'Alessandro U Dobano C Gesase S Greenwood B Grimsby J Tinto H Hamel MJ Hoffman I Kamthunzi P Kariuki S Kremsner PG Leach A Lell B Lennon NJ Lusingu J Marsh K Martinson F Molel JT Moss EL Njuguna P Ockenhouse CF Ogutu BR Otieno W Otieno L Otieno K Owusu-Agyei S Park DJ Pelle K Robbins D Russ C Ryan EM Sacarlal J Sogoloff B Sorgho H Tanner M Theander T Valea I Volkman SK Yu Q Lapierre D Birren BW Gilbert PB Wirth DF
N Engl J Med, (2015). 373:2025-2037

Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure.Olotu A Fegan G Wambua J Nyangweso G Awuondo KO Leach A Lievens M Leboulleux D Njuguna P Peshu N Marsh K Bejon P
N Engl J Med, (2013). 368:1111-20

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.Rts SClinical Trials Partnership Agnandji ST Lell B Fernandes JF Abossolo BP Methogo BG Kabwende AL Adegnika AA Mordmuller B Issifou S Kremsner PG Sacarlal J Aide P Lanaspa M Aponte JJ Machevo S Acacio S Bulo H Sigauque B Macete E Alonso P Abdulla S Salim N Minja R Mpina M Ahmed S Ali AM Mtoro AT Hamad AS Mutani P Tanner M Tinto H D'Alessandro U Sorgho H Valea I Bihoun B Guiraud I Kabore B Sombie O Guiguemde RT Ouedraogo JB Hamel MJ Kariuki S Oneko M Odero C Otieno K Awino N McMorrow M Muturi-Kioi V Laserson KF Slutsker L Otieno W Otieno L Otsyula N Gondi S Otieno A Owira V Oguk E Odongo G Woods JB Ogutu B Njuguna P Chilengi R Akoo P Kerubo C Maingi C Lang T Olotu A Bejon P Marsh K Mwambingu G Owusu-Agyei S Asante KP Osei-Kwakye K Boahen O Dosoo D Asante I Adjei G Kwara E Chandramohan D Greenwood B Lusingu J Gesase S Malabeja A Abdul O Mahende C Liheluka E Malle L Lemnge M Theander TG Drakeley C Ansong D Agbenyega T Adjei S Boateng HO Rettig T Bawa J Sylverken J Sambian D Sarfo A Agyekum A Martinson F Hoffman I Mvalo T Kamthunzi P Nkomo R Tembo T Tegha G Tsidya M Kilembe J Chawinga C Ballou WR Cohen J Guerra Y Jongert E Lapierre D Leach A Lievens M Ofori-Anyinam O Olivier A Vekemans J Carter T Kaslow D Leboulleux D Loucq C Radford A Savarese B Schellenberg D Sillman M Vansadia P
N Engl J Med, (2012). 367:2284-95

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.Rts SClinical Trials Partnership Agnandji ST Lell B Soulanoudjingar SS Fernandes JF Abossolo BP Conzelmann C Methogo BG Doucka Y Flamen A Mordmuller B Issifou S Kremsner PG Sacarlal J Aide P Lanaspa M Aponte JJ Nhamuave A Quelhas D Bassat Q Mandjate S Macete E Alonso P Abdulla S Salim N Juma O Shomari M Shubis K Machera F Hamad AS Minja R Mtoro A Sykes A Ahmed S Urassa AM Ali AM Mwangoka G Tanner M Tinto H D'Alessandro U Sorgho H Valea I Tahita MC Kabore W Ouedraogo S Sandrine Y Guiguemde RT Ouedraogo JB Hamel MJ Kariuki S Odero C Oneko M Otieno K Awino N Omoto J Williamson J Muturi-Kioi V Laserson KF Slutsker L Otieno W Otieno L Nekoye O Gondi S Otieno A Ogutu B Wasuna R Owira V Jones D Onyango AA Njuguna P Chilengi R Akoo P Kerubo C Gitaka J Maingi C Lang T Olotu A Tsofa B Bejon P Peshu N Marsh K Owusu-Agyei S Asante KP Osei-Kwakye K Boahen O Ayamba S Kayan K Owusu-Ofori R Dosoo D Asante I Adjei G Adjei G Chandramohan D Greenwood B Lusingu J Gesase S Malabeja A Abdul O Kilavo H Mahende C Liheluka E Lemnge M Theander T Drakeley C Ansong D Agbenyega T Adjei S Boateng HO Rettig T Bawa J Sylverken J Sambian D Agyekum A Owusu L Martinson F Hoffman I Mvalo T Kamthunzi P Nkomo R Msika A Jumbe A Chome N Nyakuipa D Chintedza J Ballou WR Bruls M Cohen J Guerra Y Jongert E Lapierre D Leach A Lievens M Ofori-Anyinam O Vekemans J Carter T Leboulleux D Loucq C Radford A Savarese B Schellenberg D Sillman M Vansadia P
N Engl J Med, (2011). 365:1863-75

CISH and susceptibility to infectious diseases.Khor CC Vannberg FO Chapman SJ Guo H Wong SH Walley AJ Vukcevic D Rautanen A Mills TC Chang KC Kam KM Crampin AC Ngwira B Leung CC Tam CM Chan CY Sung JJ Yew WW Toh KY Tay SK Kwiatkowski D Lienhardt C Hien TT Day NP Peshu N Marsh K Maitland K Scott JA Williams TN Berkley JA Floyd S Tang NL Fine PE Goh DL Hill AV
N Engl J Med, (2010). 362:2092-101

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.Bejon P Lusingu J Olotu A Leach A Lievens M Vekemans J Mshamu S Lang T Gould J Dubois MC Demoitie MA Stallaert JF Vansadia P Carter T Njuguna P Awuondo KO Malabeja A Abdul O Gesase S Mturi N Drakeley CJ Savarese B Villafana T Ballou WR Cohen J Riley EM Lemnge MM Marsh K von Seidlein L
N Engl J Med, (2008). 359:2521-32

Bacteremia among children admitted to a rural hospital in Kenya.Berkley JA Lowe BS Mwangi I Williams T Bauni E Mwarumba S Ngetsa C Slack MP Njenga S Hart CA Maitland K English M Marsh K Scott JA
N Engl J Med, (2005). 352:39-47

Indicators of life-threatening malaria in African children.Marsh K Forster D Waruiru C Mwangi I Winstanley M Marsh V Newton C Winstanley P Warn P Peshu N et al,
N Engl J Med, (1995). 332:1399-404